NCS Multistage (NCSM) Expected to Announce Earnings on Wednesday

Key Points

• NCS Multistage (NASDAQ:NCSM) is set to announce its Q3 2025 earnings on October 29th, with analysts expecting earnings of $1.17 per share and revenue of $46.10 million.
• In a recent transaction, Director Valerie A. Mitchell sold 1,969 shares of the company, marking a 7.72% decrease in her ownership stake.
• NCS Multistage's stock last traded at $41.30, showing a P/E ratio of 8.66 and a market capitalization of $104.90 million.

NCS Multistage (NASDAQ:NCSM - Get Free Report) is expected to be posting its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect NCS Multistage to post earnings of $1.17 per share and revenue of $46.10 million for the quarter. Interested persons are encouraged to explore the company's upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, October 30, 2025 at 8:30 AM ET.

NCS Multistage (NASDAQ:NCSM - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.34 EPS for the quarter, topping the consensus estimate of ($1.46) by $1.80. NCS Multistage had a return on equity of 12.50% and a net margin of 7.18%.The firm had revenue of $36.45 million for the quarter, compared to the consensus estimate of $27.60 million.

NCS Multistage Stock Down 0.1%

NASDAQ NCSM opened at $41.30 on Wednesday. The stock's 50-day moving average price is $43.08 and its 200-day moving average price is $34.77. The company has a quick ratio of 2.83, a current ratio of 4.66 and a debt-to-equity ratio of 0.04. NCS Multistage has a 52 week low of $17.30 and a 52 week high of $53.69. The company has a market capitalization of $104.90 million, a P/E ratio of 8.66 and a beta of 0.75.

Insiders Place Their Bets

In other NCS Multistage news, Director Valerie A. Mitchell sold 1,969 shares of NCS Multistage stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $30.16, for a total transaction of $59,385.04. Following the completion of the sale, the director directly owned 23,551 shares of the company's stock, valued at $710,298.16. The trade was a 7.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 10.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

An institutional investor recently raised its position in NCS Multistage stock. Empowered Funds LLC raised its position in shares of NCS Multistage Holdings, Inc. (NASDAQ:NCSM - Free Report) by 7.3% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 21,489 shares of the company's stock after purchasing an additional 1,455 shares during the quarter. Empowered Funds LLC owned 0.85% of NCS Multistage worth $752,000 at the end of the most recent reporting period. Institutional investors own 70.91% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on NCSM. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of NCS Multistage in a research note on Wednesday, October 8th. Zacks Research downgraded NCS Multistage from a "strong-buy" rating to a "hold" rating in a research note on Friday, October 3rd. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, NCS Multistage currently has an average rating of "Hold".

About NCS Multistage

NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and construction, and field development strategies in the United States, Canada, and internationally. It offers fracturing systems, which include casing-installed sliding sleeves, downhole frac isolation assemblies, and sand jet perforating products; enhanced recovery products, such as sliding sleeve, as well as Terrus system, an injection control device; repeat precision products comprising composite frac plugs and bridge plugs, single-use disposable setting tools, express systems, and related products; chemical and radioactive tracer diagnostics services; and well construction products, including AirLock casing buoyancy system, Vecturon and Vectraset liner hanger systems, and Toe initiation sleeves.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.